Shaping the future of regenerative medicine

BIONCaRT GmbH specializes in the development of stem cell-based drugs for clinical use in humans. Our focus is on innovative allogeneic therapy concepts for the treatment of orthopaedic diseases.

Our Mission

BIONCaRT GmbH has been actively engaged in the biotechnology and life sciences sector, with a strong focus on regenerative medicine applications. As a research-driven pharmaceutical company, we specialize in the development of advanced biomedical therapies for clinical use in humans—particularly for the treatment of orthopedic conditions. Our primary emphasis lies in the development, regulatory approval, and manufacturing of allogeneic, stem cell-based medicinal products.

BionPlanta - today BIONCaRT / CartiCure - today MesemCart

Milestones of BIONCaRT GmbH

Foundation of BioPlanta GmbH and Start of Development of an Allogeneic Cell Therapy Product from Mesenchymal Stromal Cells (MesemCart)

Successful Preclinical Safety Testing in the Mouse Model

IQ Innovation Award Central Germany

Renaming to BIONCaRT GmbH

Start of the Phase I/IIa Clinical Trial for the Market Approval of MesemCart for the Treatment of Focal Cartilage Damage in the Knee Joint

Planned Market Entry in Germany

Planned European Market Approval

Planned Approval by the FDA (U.S. Food and Drug Administration)

BIONCaRT Management

Dr. André Gerth

Dr. André Gerth brings extensive leadership experience in small and medium-sized biotech enterprises. With a strong track record in corporate development, he is recognized as a trusted and capable partner within the industry. His in-depth expertise in international B2B business spans European, Central and South American, and Asian markets. As a dedicated advocate of biotechnology, Dr. Gerth drives innovation and supports companies in achieving their strategic goals.

1992 -2011
Founder and Managing Director of BioPlanta GmbH
2012-2017
Chairman of the Management Board of Vita 34 AG
2017-today
Founder and Managing Director of BIONCaRT GmbH

Dr. Heike Opitz

Dr. Heike Opitz brings extensive experience in managing collaborative projects and overseeing the planning and execution of research and development (R&D) initiatives. Her expertise lies particularly in the development and regulatory approval of stem cell therapies and medical products.

1992 -1997
Founder and Business Development Manager at BioPlanta GmbH
1997-2001
Project Manager in Companies, in the Economic Development Department of the Leipzig Regional Council and the University of Leipzig
2001-2018
Business Development Manager at Vita 34 AG
2019-today
Business Development Manager at BIONCaRT GmbH

Thank you for your interest in joining BIONCaRT. While we currently have no open positions, we appreciate your enthusiasm and encourage you to check back regularly — new opportunities may arise at any time!